(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TESORX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TESORX

ST13

US500000086431639

Class

42

Filing

86431639

Registration

5131036

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

02/01/2026

Trademark type

Combined

Nice classes

42

Filing date

10/22/2014

Registration date

01/31/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/26/2023

Last transaction

02/01/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

04/30/2010

First use in commerce

04/30/2010

Drawing code

3

Owner type

16

Owner location

Menlo Park, CA

Examiner

YONTEF, DAVID ERIC

Law office

M90

Current location

TMO LAW OFFICE 118

Mark description

The mark consists of the wording "TESORX" in stylized font whereby a curved line appears above the letter "O".

Holders and representatives

Holders

Tesorx Pharma, LLC

Representatives

Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services

Publications

History of USPTO decisions and trademark events.

34 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/31/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/26/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/26/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/26/2023

E815

TEAS SECTION 8 & 15 RECEIVED

01/31/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/31/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

01/31/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/15/2016

PUBO

PUBLISHED FOR OPPOSITION

11/15/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/26/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/11/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/08/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/08/2016

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

04/05/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/29/2015

GNSL

LETTER OF SUSPENSION E-MAILED

09/29/2015

CNSL

SUSPENSION LETTER WRITTEN

09/29/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/09/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2015

ALIE

ASSIGNED TO LIE

09/02/2015

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

08/18/2015

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

08/18/2015

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/18/2015

GNSL

LETTER OF SUSPENSION E-MAILED

02/18/2015

CNSL

SUSPENSION LETTER WRITTEN

02/18/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

02/18/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/18/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

02/18/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/18/2015

DOCK

ASSIGNED TO EXAMINER

02/10/2015

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/31/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/30/2014

NWAP

NEW APPLICATION ENTERED

10/27/2014

Continuous trademark protection

Get notified about every new filing that threatens TESORX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.